Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Jia‐Ying Mao"'
Autor:
Xue-Ping Li, Jiang-Tao Song, Yu-Ting Dai, Wei-Na Zhang, Bai-Tian Zhao, Jia-Ying Mao, Yan Gao, Lu Jiang, Yang Liang
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionImmunotherapies targeting T cells in solid cancers are revolutionizing clinical treatment. Novel immunotherapies have had extremely limited benefit for acute myeloid leukemia (AML). Here, we characterized the immune microenvironment of t(
Externí odkaz:
https://doaj.org/article/292b04f80fef4aac9c35615b1ec1a56b
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Background Acute Myeloid Leukemia (AML) is a hematological cancer characterized by heterogeneous hematopoietic cells. Through the use of multidimensional sequencing technologies, we previously identified a distinct myeloblast population, CD3
Externí odkaz:
https://doaj.org/article/7252dd7e2b294f08b95e1e83788e8b0f
Autor:
Hai‐Xia He, Yan Gao, Bing Bai, Xiao‐Xiao Wang, Ji‐Bin Li, Cheng Huang, Jia‐Ying Mao, Li‐Qin Ping, Qi‐Xiang Rong, Yan‐Xia He, He Huang, Qing‐Qing Cai, Zhi‐Ming Li, Wen‐Qi Jiang, Hui‐Qiang Huang
Publikováno v:
Cancer Medicine, Vol 10, Iss 21, Pp 7650-7664 (2021)
Abstract Purpose Some studies have indicated that using 500 mg/m2 rituximab combined with CHOP‐14 may be beneficial for elderly men but not women with diffuse large B‐cell lymphoma (DLBCL). The purpose of this study was to investigate the potenti
Externí odkaz:
https://doaj.org/article/a921548233734c3d8c5113b7e54a90cf
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Acute myeloid leukemia (AML) is a highly heterogeneous hematological malignancy that imposes great challenges in terms of drug resistance and relapse. Previous studies revealed heterogeneous leukemia cells and their relevant gene markers, such as CRI
Externí odkaz:
https://doaj.org/article/0f895c7539594b02adf4622d226b19bf
Autor:
Zi-Shan Hong, Jing Xie, Xue-Feng Wang, Jing-Jing Dai, Jia-Ying Mao, Yu-Ying Bai, Jun Sheng, Yang Tian
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Ulcerative colitis is a chronic inflammatory bowel disease (IBD), but progress in exploring its pathogenesis and finding effective drugs for its prevention and treatment has stalled in recent years. The seeds of Moringa oleifera Lam. are rich in prot
Externí odkaz:
https://doaj.org/article/2960c924a88b489f83df3acd471db4c6
Autor:
Jing Xie, Ying-Yan Qian, Yang Yang, Lin-Jie Peng, Jia-Ying Mao, Ming-Rong Yang, Yang Tian, Jun Sheng
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2022)
Moringa oleifera Lam. is a tropical and subtropical plant that has been used for centuries as both food and traditional medicine. 4-[(α-L-Rhamnosyloxy) benzyl] isothiocyanate (MIC-1) is an active substance in M. oleifera, with anti-cancer activity.
Externí odkaz:
https://doaj.org/article/63ca8978864c4ad98aa5cd09b4b80eab
Publikováno v:
Biomolecules, Vol 12, Iss 10, p 1359 (2022)
Acute myeloid leukemia (AML) is a biologically and genetically heterogeneous hematological malignance with an unsatisfactory risk stratification system. Recently, through the novel single-cell RNA sequencing technology, we revealed heterogeneous leuk
Externí odkaz:
https://doaj.org/article/1aad2ae163254ec1aa25f4d4aabd7650
Autor:
Hai-Xia He, Yan Gao, Jian-Chang Fu, Qiang-Hua Zhou, Xiao-Xiao Wang, Bing Bai, Peng-Fei Li, Cheng Huang, Qi-Xiang Rong, Li-Qin Ping, Yan-Xia He, Jia-Ying Mao, Xu Chen, Hui-Qiang Huang
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Although PD-1/PD-L1 blockade therapy confers salutary effects across cancer types, their efficacy in Extranodal Natural killer/T-cell lymphoma (ENKTCL) patients is limited and unpredictable. Here, we comprehensively evaluated the expression profile o
Externí odkaz:
https://doaj.org/article/6259b50825fb4839b0f278cd8a695dc1
Autor:
Wenqi Jiang, Li-Qin Ping, Qingqing Cai, Bing Bai, Xiaoxiao Wang, Jibin Li, Qixiang Rong, Jia-Ying Mao, Yan-Xia He, Haixia He, Cheng Huang, Yan Gao, Zhi Ming Li, He Huang, Huiqiang Huang
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 21, Pp 7650-7664 (2021)
Cancer Medicine, Vol 10, Iss 21, Pp 7650-7664 (2021)
Purpose Some studies have indicated that using 500 mg/m2 rituximab combined with CHOP‐14 may be beneficial for elderly men but not women with diffuse large B‐cell lymphoma (DLBCL). The purpose of this study was to investigate the potential benefi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65e0dc1a07dd1b3f1d3bfeebc870ab59
https://doi.org/10.1002/cam4.4296
https://doi.org/10.1002/cam4.4296
Publikováno v:
Journal of translational medicine. 20(1)
Acute Myeloid Leukemia (AML) is a hematological cancer characterized by heterogeneous hematopoietic cells. Through the use of multidimensional sequencing technologies, we previously identified a distinct myeloblast population, CD34Based on the CD34Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::35e4ac9b0d7de78b122bff30067694f0
https://pubmed.ncbi.nlm.nih.gov/35962395
https://pubmed.ncbi.nlm.nih.gov/35962395